Risk of local and systemic infection with polyethylene intravenous catheters. A prospective study of 213 catheterizations.

PubWeight™: 3.00‹?› | Rank: Top 1%

🔗 View Article (PMID 4969435)

Published in N Engl J Med on August 15, 1968

Authors

R N Collins, P A Braun, S H Zinner, E H Kass

Articles citing this

Experimental endocarditis. II. Staphylococcal infection of the aortic valve following placement of a polyethylene catheter in the left side of the heart. Yale J Biol Med (1971) 7.03

Subclavian vein catheterizations: a prospective study. II. Infectious complications. Ann Surg (1971) 1.63

Is semiquantitative culture of central vein catheter tips useful in the diagnosis of catheter-associated bacteremia? J Clin Microbiol (1986) 1.60

Septic and technical complications of central venous catheterization. A prospective study of 200 consecutive patients. Ann Surg (1985) 1.39

Prolonged parenteral alimentation: Candida growth and the prevention of candidemia by amphotericin instillation. Ann Surg (1972) 1.15

Microbiology of indwelling central intravascular catheters. J Clin Microbiol (1988) 1.14

Pseudomonas pickettii bacteremia. J Clin Microbiol (1981) 1.11

Molecular epidemiology of clinical and carrier strains of methicillin resistant Staphylococcus aureus (MRSA) in the hospital settings of north India. Ann Clin Microbiol Antimicrob (2006) 1.07

Thrombophlebitis following intravenous anesthesia and sedation: an annotated literature review. Anesth Prog (1978) 0.89

Drug fever. West J Med (1978) 0.89

Infusion catheter sepsis: an increasing threat. Ann Surg (1971) 0.88

Contaminated stethoscopes: a potential source of nosocomial infections. Yale J Biol Med (1972) 0.85

A comprehensive surveillance system of infections and antimicrobials use at Presbyterian-St. Luke's Hospital, Chicago. Am J Public Health (1972) 0.82

Effect of a Millipore filter on complications of intravenous infusions: a prospective clinical trial. Br Med J (1973) 0.81

Infectious complications of intravenous polyethylene catheters. Calif Med (1971) 0.81

An assessment of the role of parenteral alimentation in the management of surgical patients. Ann Surg (1973) 0.80

Fungal septicemia in surgical patients. Ann Surg (1974) 0.79

Intravenous fluids in medical in-patients. Br J Clin Pharmacol (1977) 0.79

Pseudomonas cepacia septicemia associated with intravenous therapy. Calif Med (1973) 0.78

Intravenous catheter-associated bacteremia: role of the diagnostic microbiology laboratory. Appl Microbiol (1973) 0.76

Septic superficial thrombophlebitis: a major threat from a minor lesion. Can Med Assoc J (1976) 0.75

Control of infection after thoracic and cardiovascular surgery. Ann Surg (1970) 0.75

Double-blind prospective randomized study comparing topical mupirocin and placebo for the prevention of infection associated with central venous catheters. Can J Infect Dis (1997) 0.75

Septicemia. Can Fam Physician (1976) 0.75

Pathogenesis and prevention of intravenous catheter infections. Yale J Biol Med (1973) 0.75

Infectious diseases. Annual review of significant publications. Postgrad Med J (1969) 0.75

Articles by these authors

Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance. Antimicrob Agents Chemother (1987) 5.17

Bacteriuria of pregnancy--a critical appraisal. Annu Rev Med (1968) 3.95

Sec2p mediates nucleotide exchange on Sec4p and is involved in polarized delivery of post-Golgi vesicles. J Cell Biol (1997) 3.94

Familial aggregation of blood pressure in childhood. N Engl J Med (1971) 3.27

Fifteen-month follow-up study of women infected with Chlamydia trachomatis. N Engl J Med (1979) 3.26

THE OCCURRENCE OF NORMAL SERUM GAMMA-GLOBULIN IN HUMAN LYMPHOCYTES. Science (1945) 3.21

Serratia marcescens: biochemical, serological, and epidemiological characteristics and antibiotic susceptibility of strains isolated at Boston City Hospital. Appl Microbiol (1970) 2.83

Two compartment kinetic model with multiple artificial capillary units. J Antimicrob Chemother (1985) 2.62

Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA. J Infect Dis (2000) 2.55

Thomas Hodgkin and Benjamin Harrison: crisis and promotion in academia. Med Hist (1980) 2.44

Antibacterial mechanisms of the urinary bladder. J Clin Invest (1968) 2.31

Vaginal colonization with Corynebacterium vaginale (Haemophilus vaginalis). J Infect Dis (1977) 2.23

The genital mycoplasmas. N Engl J Med (1973) 2.21

Significance of blood pressure in infancy. Familial aggregation and predictive effect on later blood pressure. Hypertension (1985) 2.20

Sexual behavior of college women in 1975, 1986, and 1989. N Engl J Med (1990) 2.18

Mechanisms of antibacterial action in the respiratory system. Bacteriol Rev (1966) 2.15

Susceptibility of genital mycoplasmas to antimicrobial agents. Appl Microbiol (1970) 2.13

Age-specific correlation analysis of longitudinal blood pressure data. Am J Epidemiol (1977) 2.10

Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules. Vaccine (2000) 2.07

The influence of bacterial species on pulmonary resistance to infection in mice subjected to hypoxia, cold stress, and ethanolic intoxication. Br J Exp Pathol (1965) 2.03

Methodologic investigations and prevalence of genital mycoplasmas in pregnancy. J Infect Dis (1970) 2.02

Bacteremia due to serratia marcescens. N Engl J Med (1968) 1.96

Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group. J Infect Dis (1978) 1.89

Efficacy of intermittent versus continuous administration of netilmicin in a two-compartment in vitro model. Antimicrob Agents Chemother (1985) 1.86

A simple method for quantitative urine culture. N Engl J Med (1967) 1.85

Serologic typing of human genital T-mycoplasmas by a complement-dependent mycoplasmacidal test. J Infect Dis (1972) 1.82

Moxalactam therapy of infections caused by cephalothin-resistant bacteria: influence of serum inhibitory activity on clinical response and acquisition of antibiotic resistance during therapy. Antimicrob Agents Chemother (1981) 1.81

Antistaphylococcal activity of rifampin with other antibiotics. J Infect Dis (1981) 1.78

Vaginal colonization with group B streptococcus: a study in college women. J Infect Dis (1977) 1.76

Hepatotoxicity of erythromycin estolate during pregnancy. Antimicrob Agents Chemother (1977) 1.75

Stability of blood pressure rank and urinary kallikrein concentration in childhood: an eight-year follow-up. Circulation (1978) 1.75

Pharmacodynamics of piperacillin alone and in combination with tazobactam against piperacillin-resistant and -susceptible organisms in an in vitro model of infection. Antimicrob Agents Chemother (1994) 1.70

Methods for quantitative and qualitative evaluation of vaginal microflora during menstruation. Appl Environ Microbiol (1986) 1.67

Interaction of magnesium ion, oxygen tension, and temperature in the production of toxic-shock-syndrome toxin-1 by Staphylococcus aureus. J Infect Dis (1987) 1.66

Synergistic combinations of antibiotics in gram-negative bacillary infections. Rev Infect Dis (1982) 1.62

Chlamydia trachomatis in women: antibody in cervical secretions as a possible indicator of genital infection. J Infect Dis (1979) 1.60

Plasma lipids and lipoproteins in vegetarians and controls. N Engl J Med (1975) 1.59

Demographic and prognostic characteristics of bacteriuria in pregnancy. Medicine (Baltimore) (1967) 1.58

Interstate outbreak of Salmonella newbrunswick infection traced to powdered milk. JAMA (1968) 1.50

Quantitative assessment of vaginal microflora during use of tampons of various compositions. Appl Environ Microbiol (1987) 1.50

Influence of medium and method on the in vitro susceptibility of Pseudomonas aeruginosa and other bacteria to ciprofloxacin and enoxacin. Antimicrob Agents Chemother (1986) 1.49

Birth weight and genital mycoplasmas in pregnancy. N Engl J Med (1971) 1.48

Isolation of Eikenella corrodens in a general hospital. Appl Microbiol (1973) 1.48

Qualitative assessment of vaginal microflora during use of tampons of various compositions. Appl Environ Microbiol (1987) 1.47

Pharmacokinetics and pharmacodynamics of intravenous ciprofloxacin. Studies in vivo and in an in vitro dynamic model. Am J Med (1987) 1.43

Immune inactivation of T-strain mycoplasmas. J Infect Dis (1970) 1.42

Effect of intranasal reovirus infection on antibacterial activity of mouse lung. J Infect Dis (1969) 1.41

Ethical considerations in the planning of hypertension treatment trials. Ann N Y Acad Sci (1978) 1.41

Blood pressure in vegetarians. Am J Epidemiol (1974) 1.40

Erythromycin plus alkalinization in treatment of urinary infections. Antimicrob Agents Chemother (Bethesda) (1969) 1.40

Predictors of effect of ampicillin-sulbactam against TEM-1 beta-lactamase-producing Escherichia coli in an in vitro dynamic model: enzyme activity versus MIC. Antimicrob Agents Chemother (1996) 1.39

Long-term (10 to 14 years) follow-up of bacteriuria of pregnancy. N Engl J Med (1971) 1.38

Inter- and intraquinolone predictors of antimicrobial effect in an in vitro dynamic model: new insight into a widely used concept. Antimicrob Agents Chemother (1998) 1.37

2',3'-didehydro-3'-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trial. J Infect Dis (1993) 1.37

Household aggregation of pulmonary function and chronic bronchitis. Am Rev Respir Dis (1976) 1.36

Pathogenesis and prognosis of prematurity. N Engl J Med (1966) 1.34

Thomas Hodgkin, M. D. (1798-1866): an annotated bibliography. Bull Hist Med (1969) 1.34

Significance of "extravascular" protein binding for antimicrobial pharmacodynamics in an in vitro capillary model of infection. Antimicrob Agents Chemother (1990) 1.31

Impact of netilmicin regimens on the activities of ceftazidime-netilmicin combinations against Pseudomonas aeruginosa in an in vitro pharmacokinetic model. Antimicrob Agents Chemother (1985) 1.30

Dose ranging and fractionation of intravenous ciprofloxacin against Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro model of infection. Antimicrob Agents Chemother (1993) 1.30

Maternal smoking: a reassessment of the association with perinatal mortality. Am J Epidemiol (1972) 1.29

Sexual experience and urethral colonization with genital mycoplasmas. A study in normal men. Ann Intern Med (1973) 1.28

Use of antimicrobial drugs in general hospitals: patterns of prophylaxis. N Engl J Med (1979) 1.28

Antibiotic irrigation and catheter-associated urinary-tract infections. N Engl J Med (1978) 1.27

A longitudinal study of blood pressure in childhood. Am J Epidemiol (1974) 1.27

Pathogenesis and prognosis of prematurity. N Engl J Med (1966) 1.26

Infection with Chlamydia trachomatis in female college students. Am J Epidemiol (1985) 1.25

Effects of IgM and IgG antibody in patients with bacteremia due to gram-negative bacilli. J Infect Dis (1976) 1.24

Identification of a Sec4p GTPase-activating protein (GAP) as a novel member of a Rab GAP family. J Biol Chem (1998) 1.21

Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia. The EORTC International Antimicrobial Therapy Cooperative Group. N Engl J Med (1987) 1.21

Serotypic heterogeneity in isolates of human genital T-mycoplasmas. Infect Immun (1973) 1.21

Effect of mixing on rifampin bactericidal activity against staphylococci. Antimicrob Agents Chemother (1981) 1.21

Beta-carotene as a photoprotective agent in erythropoietic protoporphyria. N Engl J Med (1970) 1.19

Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program. Antimicrob Agents Chemother (1996) 1.19

Erythromycin and alkalinisation of urine in the treatment of urinary-tract infections due to gram-negative bacilli. Lancet (1971) 1.18

Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients. Antimicrob Agents Chemother (1986) 1.17

The natural history of asymptomatic bacteriuria during pregnancy: the effect of tetracycline on the clinical course and the outcome of pregnancy. Am J Obstet Gynecol (1971) 1.17

In vitro models for the study of antibiotic activities. Prog Drug Res (1987) 1.14

Efficacy of standard disc-diffusion test as applied to susceptibility of Staphylococcus aureus to tetracycline and minocycline. J Lab Clin Med (1972) 1.13

In vitro models for the study of combination antibiotic therapy in neutropenic patients. Am J Med (1986) 1.13

Combination therapy with ciprofloxacin plus azlocillin against Pseudomonas aeruginosa: effect of simultaneous versus staggered administration in an in vitro model of infection. J Infect Dis (1991) 1.13

Ingestion of egg raises plasma low density lipoproteins in free-living subjects. Lancet (1984) 1.12

Familial aggregation of blood pressures of newborn infants and their mother. Pediatrics (1976) 1.11

Synergistic activity of trimethoprim and amikacin against gram-negative bacilli. Antimicrob Agents Chemother (1977) 1.11

Risk of infection with intravenous indwelling catheters: effect of application of antibiotic ointment. J Infect Dis (1969) 1.11

Pathogenesis and prognosis of prematurity. N Engl J Med (1966) 1.11

Septicemia caused by Vibrio fetus. Arch Intern Med (1970) 1.10

Comparison of tube dilution and microtitre methods for the detection of antibiotic tolerance in strains of Staphylococcus aureus. J Antimicrob Chemother (1984) 1.10

Effects of cigarette smoking on fasting triglyceride, total cholesterol, and HDL-cholesterol in women. Am Heart J (1983) 1.09

Yop1p, the yeast homolog of the polyposis locus protein 1, interacts with Yip1p and negatively regulates cell growth. J Biol Chem (2001) 1.09

Effect of clindamycin on the in vitro activity of amikacin and gentamicin against gram-negative bacilli. Antimicrob Agents Chemother (1976) 1.09

Comparison of methods for the isolation of genital mycoplasmas from men. J Infect Dis (1976) 1.09

Genital mycoplasmas as a cause of excess premature delivery. Trans Assoc Am Physicians (1981) 1.08

Serological reactions of Mycoplasma hominis: differences among mycoplasmacidal, metabolic inhibition, and growth agglutination tests. Infect Immun (1974) 1.08